BMO Capital Maintains Their Buy Rating on CareTrust REIT (CTRE)


In a report released today, John Kim from BMO Capital maintained a Buy rating on CareTrust REIT (CTRE), with a price target of $22. The company’s shares closed yesterday at $22.03, close to its 52-week high of $22.66.

According to TipRanks.com, Kim is a 4-star analyst with an average return of 4.8% and a 59.8% success rate. Kim covers the Financial sector, focusing on stocks such as Apartment Investment & Management, Franklin Street Properties, and National Health Investors.

CareTrust REIT has an analyst consensus of Strong Buy, with a price target consensus of $22.33, implying a 1.4% upside from current levels. In a report issued on February 7, Raymond James also maintained a Buy rating on the stock with a $24 price target.

See today’s analyst top recommended stocks >>

The company has a one-year high of $22.66 and a one-year low of $12.73. Currently, CareTrust REIT has an average volume of 985.3K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

CareTrust REIT, Inc. is a real estate investment company, which engages in the ownership, acquisition, and leasing of healthcare-related properties. It offers independent living, memory care, and assisted, and skilled nursing facilities. The company was founded on October 29, 2013 and is headquartered in San Clemente, CA.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts